Competitive Landscape The global direct-to-consumer weight-loss medication market is moderately consolidated, with a few pharmaceutical companies dominating the majority of the market share
Cost-effectiveness of long-acting insulin analogues vs intermediate/long-acting human insulin for type 1 diabetes: a population-based cohort followed over 10 years
Think of it this way: if Saxenda is opening one door to appetite control, Mounjaro is opening two doors simultaneously, often leading to a more profound impact
[10] [11] Based on data from retatrutide clinical trials (NEJM, 2023) and experience with similar approved agents, patients may experience: Redness, swelling, or itching at the injection site, which typically resolves within a few hours to days Bruising or mild pain immediately following injection Nodules or localised reactions beneath the skin, which may occur with repeated injections at the same site These reactions are generally mild and self-limiting
Very clean and comfortable setting